Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Soins. Gerontologie|May 16, 2019
[Clinical trials and elderly patients with cancer, the Geriatric Core Dataset (G-Code) tool]Elena Paillaud, Tristan Cudennec, Philippe Caillet, et al.
Journal of Geriatric Oncology|January 15, 2019
The prognostic value of G8 for functional declineCamille Chakiba, Carine Bellera, Fanny Etchepare, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 18, 2007
The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelinesMatti Aapro, Ivo Abraham, Carsten Bokemeyer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2008
Vulnerable and frail elderly: an approach to the management of the main tumour typesSilvio Monfardini, Cesare Gridelli, Lara M Pasetto, et al.
Anticancer Research|September 10, 2014
Granulocyte-colony-stimulating factor in elderly patients receiving chemotherapy for breast and gynaecological cancers: results of a French surveyClaire Falandry, Ivan Krakowski, Hervé Curé, et al.
BMJ Supportive & Palliative Care|July 19, 2020
Palliative versus hospice care in patients with cancer: a systematic reviewMatthieu Frasca, Angeline Galvin, Chantal Raherison, et al.
Cancer Treatment Reviews|March 12, 2013
Barriers to inclusion of older adults in randomised controlled clinical trials on Non-Hodgkin's lymphoma: a systematic reviewCarine Bellera, Delphine Praud, Aurélie Petit-Monéger, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2016
Targeted therapy and elderly people: A reviewAmaury Daste, Camille Chakiba, Charlotte Domblides, et al.
Cancers|December 24, 2021
Cognitive Impairment in Older Cancer Patients Treated with First-Line ChemotherapyMélanie Dos Santos, Idlir Licaj, Carine Bellera, et al.
Leukemia & Lymphoma|May 13, 2006
Aggressive non-Hodgkin's lymphoma: concomitant evaluation of interleukin-2, soluble interleukin-2 receptor, interleukin-4, interleukin-6, interleukin-10 and correlation with outcomeElizabeth Fabre-Guillevin, Reza Tabrizi, Valérie Coulon, et al.
Pageof 12